Merle, Philippe

Publishing since 1996 (Senior)

Has published 29 publications in 15 years

Number of publications published per year by Merle, Philippe. (Source : PubMed)

Distribution of publications types for Merle, Philippe. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Bathaix F, Marion D, Cuinet M, Maillard E, Zoulim F, Mornex F, Merle P. Markedly effective local control of hepatocellular carcinoma with a poor prognosis by combined multimodal therapy with sorafenib as a neoadjuvant approach. Gastroenterol. Clin. Biol. 2010
Merle P, Mornex F, Trepo C. Innovative therapy for hepatocellular carcinoma: three-dimensional high-dose photon radiotherapy. Cancer Lett. 2009;286;1
Bengochea A, de Souza MM, Lefrançois L, Le Roux E, Galy O, Chemin I, Kim M, Wands JR, Trepo C, Hainaut P, Scoazec JY, Vitvitski L, Merle P. Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br. J. Cancer 2008;99;1
Kim M, Lee HC, Tsedensodnom O, Hartley R, Lim YS, Yu E, Merle P, Wands JR. Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. J. Hepatol. 2008;48;5
Merle P, Morvan D, Caillaud D, Demidem A. Chemotherapy-induced bystander effect in response to several chloroethylnitrosoureas: an origin independent of DNA damage? Anticancer Res. 2008;28;1A
Merle P, Morvan D, Madelmont JC, Caillaud D, Demidem A. CENU treatment induced bystander effects which are effective on parental and non-parental tumors and have a phospholipid metabolism proton NMR spectroscopy signature. Int. J. Oncol. 2006;29;3
Bonny C, Fontaine H, Poynard T, Hézode C, Larrey D, Marcellin P, Bourlière M, Bronowicki JP, Merle P, Zarski JP, Sapey T, Guillemard C, Ughetto S, Henquell C, Nicolas C, Roche C, Randl K, Bommelaer G, Abergel A. Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study. Aliment. Pharmacol. Ther. 2006;24;4
Merle P, Kim M, Herrmann M, Gupte A, Lefrançois L, Califano S, Trépo C, Tanaka S, Vitvitski L, de la Monte S, Wands JR. Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. J. Hepatol. 2005;43;5
Barraud L, Merle P, Soma E, Lefrançois L, Guerret S, Chevallier M, Dubernet C, Couvreur P, Trépo C, Vitvitski L. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J. Hepatol. 2005;42;5
Mai W, Barraud L, Lefrancois L, Scoazec JY, Guerret S, Vray D, Merle P, Vitvitski-Trepo L, Trepo C, Janier MF. Ultrasound detection of spontaneous hepato-cellular carcinomas in X/myc bitransgenic mice. Liver Int. 2004;24;6

[ See timeline ] [ See all publications ]

h=15

means that Merle, Philippe has 15 papers cited a least 15 times - methodology

Key figures

29 pub in 15 years
1.9 publications/year
best year 2004 with 6 pub
h-index 15 with 29 pub
h-ratio : 51 %

See Timeline

Ranking

It's me !

Click here if you are
Merle, Philippe.

Most frequent Journals

J. Hepatol. (6x)
Gastroenterol. Clin. Biol. (4x)
Presse Med (2x)
J. Med. Virol. (2x)
Minerva Gastroenterol Dietol (1x)

Main affiliation

INSERM, U871, 69003 Lyon, France

Latest co-workers

Barraud L Buendia MA Caux C Chemin I Chevallier M Guerret S Hainaut P Kim M Lefrançois L Mandrand B Morvan D Reynard O Scoazec JY Taverne C Trepo C Trépo C Vaure C Vitvitski L Wands JR Zoulim F

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.